Position in FTRE
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,150,182
-$956,043 QoQ
Shares Held
122,100
0.0% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ING GROEP NV holds $89,261,587 across 9 Biotechnology names. FTRE ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,425 | $29,214,879 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
31,191 | $24,099,414 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
391,500 | $10,844,550 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
103,000 | $10,016,750 | |
| 5 | NKTR |
Nektar Therapeutics
|
100,000 | $7,195,000 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
28,214 | $5,333,856 | |
| 7 | FTRE |
Fortrea Holdings Inc.
This page
|
122,100 | $1,150,182 | |
| 8 | INSM |
INSMED Inc
|
5,996 | $980,465 |
All Filings in FTRE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,150,182 | 122,100 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,106,225 | 122,100 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,004,802 | 238,100 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $1,176,214 | 238,100 | Shares | Defined | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||